Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jick

Showing results (111-120 of 265) with videos related to

Pageof 27
Sort By:
Epidemiology (Cambridge, Mass.)|July 1, 1997
Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertensionH Jick, C Vasilakis, L E Derby
JAMA|April 3, 1978
Oral contraceptives and nonfatal myocardial infarctionH Jick, B Dinan, K J Rothman
JAMA|April 3, 1978
Noncontraceptive estrogens and nonfatal myocardial infarctionH Jick, B Dinan, K J Rothman
Annals of Internal Medicine|July 1, 1978
Oral contraceptives and nonfatal stroke in healthy young womenH Jick, J Porter, K J Rothman
Journal of Clinical Pharmacology|August 1, 1981
Drug-induced liver diseaseH Jick, A M Walker, J Porter
Pharmacotherapy|March 1, 1995
The risk of sulfasalazine- and mesalazine-associated blood disordersH Jick, M W Myers, A D Dean
European Journal of Clinical Pharmacology|January 1, 1982
Drug attributed alterations in potassium handling in congestive cardiac failureD H Lawson, P C O'Connor, H Jick
British Journal of Clinical Pharmacology|May 21, 1999
Use of dexfenfluramine, fenfluramine and phentermine and the risk of strokeL E Derby, M W Myers, H Jick
American Journal of Epidemiology|January 1, 1976
Cigarette-smoking and nonfatal myocardial infarction: rate ratio in relation to age, sex and predisposing conditionsO S Miettinen, R K Neff, H Jick
Lancet (London, England)|May 8, 1993
First trimester topical tretinoin and congenital disordersS S Jick, B Z Terris, H Jick
Pageof 27

Showing results (111-120 of 265) with videos related to

Sort By:
Pageof 27
Epidemiology (Cambridge, Mass.)|July 1, 1997
Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertensionH Jick, C Vasilakis, L E Derby
JAMA|April 3, 1978
Oral contraceptives and nonfatal myocardial infarctionH Jick, B Dinan, K J Rothman
JAMA|April 3, 1978
Noncontraceptive estrogens and nonfatal myocardial infarctionH Jick, B Dinan, K J Rothman
Annals of Internal Medicine|July 1, 1978
Oral contraceptives and nonfatal stroke in healthy young womenH Jick, J Porter, K J Rothman
Journal of Clinical Pharmacology|August 1, 1981
Drug-induced liver diseaseH Jick, A M Walker, J Porter
Pharmacotherapy|March 1, 1995
The risk of sulfasalazine- and mesalazine-associated blood disordersH Jick, M W Myers, A D Dean
European Journal of Clinical Pharmacology|January 1, 1982
Drug attributed alterations in potassium handling in congestive cardiac failureD H Lawson, P C O'Connor, H Jick
British Journal of Clinical Pharmacology|May 21, 1999
Use of dexfenfluramine, fenfluramine and phentermine and the risk of strokeL E Derby, M W Myers, H Jick
American Journal of Epidemiology|January 1, 1976
Cigarette-smoking and nonfatal myocardial infarction: rate ratio in relation to age, sex and predisposing conditionsO S Miettinen, R K Neff, H Jick
Lancet (London, England)|May 8, 1993
First trimester topical tretinoin and congenital disordersS S Jick, B Z Terris, H Jick
Pageof 27